2-TUR QANDLI DIABETDA KARDIORENAL O‘ZGARISHLARNI ERTA DIAGNOSTIKA QILISH VA ULARNING PROFILAKTIKASINI OPTIMALLASHTIRISH

Authors

  • Ozodbekova Umida Abdug'opir qizi,Yusupova Shahnoza Qodirjonovna Gospital terapiya va endokrinologiya kafedrasi mudiri professor

Keywords:

2-tur qandli diabet, kardiorenal o‘zgarishlar, erta diagnostika, profilaktika, diabetik nefropatiya, yurak-qon tomir asoratlari, mikroalbuminuriya, glomerulyar filtratsiya tezligi, arterial gipertenziya, dislipidemiya.

Abstract

Mazkur tezis 2-tur qandli diabet bilan og‘rigan bemorlarda kardiorenal o‘zgarishlarni erta diagnostika qilish va ularning profilaktikasini optimallashtirish masalalariga bag‘ishlangan. Tadqiqotda qandli diabet fonida yuzaga keladigan buyrak va yurak faoliyatidagi strukturaviy hamda funksional o‘zgarishlarning o‘zaro bog‘liqligi yoritilgan. Kardiorenal asoratlarning rivojlanishida uzoq muddatli giperglikemiya, insulinrezistentlik, arterial gipertenziya, dislipidemiya, oksidlovchi stress va surunkali yallig‘lanish muhim omillar ekani ko‘rsatib o‘tilgan. Shuningdek, ushbu o‘zgarishlarni erta aniqlashda mikroalbuminuriya, albumin/kreatinin nisbati, glomerulyar filtratsiya tezligi, kreatinin, HbA1c, lipid spektri va yurakning instrumental tekshiruvlari muhim diagnostik mezon sifatida baholangan. Tezisda kardiorenal buzilishlarning oldini olish faqat glyukemik nazorat bilan cheklanib qolmasdan, balki arterial bosimni nazorat qilish, dislipidemiyani tuzatish, sog‘lom turmush tarzini shakllantirish, muntazam monitoring olib borish va zamonaviy kardio-nefroprotektiv yondashuvlarni qo‘llash orqali amalga oshirilishi asoslab berilgan. Tadqiqot natijalari 2-tur qandli diabetli bemorlarda kardiorenal asoratlarni erta aniqlash, xavf guruhlarini saralash va profilaktik choralarni takomillashtirishda amaliy аҳamiyatga ega.

References

1.American Diabetes Association Professional Practice Committee for Diabetes. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Supplement_1):S246–S260. doi:10.2337/dc26-S011.

2.American Diabetes Association Professional Practice Committee for Diabetes. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Supplement_1):S216–S245. doi:10.2337/dc26-S010.

3.Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105(4S):S117–S314. Guideline update published March 2024.

4.Marx N, Federici M, Schütt K, Mueller-Wieland D, Ajjan RA, Antunes MJ, va boshq. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. European Society of Cardiology Clinical Practice Guidelines. Published 25 August 2023.

5.Ndumele CE, Neeland IJ, Tuttle KR, va boshq. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023;148:e000–e000. American Heart Association scientific statement on CKM syndrome.

Downloads

Published

2026-04-14

Conference Proceedings Volume

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.